Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database

Vaccination against COVID-19 is the cornerstone of controlling and mitigating the ongoing pandemic. Thrombotic adverse events linked to Moderna, Pfizer and the Oxford-AstraZeneca vaccine have been documented and described as extremely rare. While the Oxford-AstraZeneca vaccine has received much of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobaiqy, Mansour, MacLure, Katie, Elkout, Hajer, Stewart, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624459/
https://www.ncbi.nlm.nih.gov/pubmed/34835256
http://dx.doi.org/10.3390/vaccines9111326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624459/
https://www.ncbi.nlm.nih.gov/pubmed/34835256
http://dx.doi.org/10.3390/vaccines9111326

Ejemplares similares